Mitchell Capital Management CO Moderna, Inc. Transaction History

Mitchell Capital Management CO

  • $549 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022
SELL
$225.82 - $368.51 $158,074 - $257,957
-700 Closed
0 $0
Q3 2021

Nov 02, 2021
SELL
$221.9 - $484.47 $44,380 - $96,894
-200 Reduced 22.22%
700 $269,000
Q2 2021

Aug 10, 2021
BUY
$129.91 - $234.98 $116,919 - $211,482
900 New
900 $211,000

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mitchell Capital Management CO Portfolio

Follow Mitchell Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Capital Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email